Study links adropin to reduced feeding in broiler chicks

A new poultry nutrition study suggests adropin may act as a central brake on feeding in neonatal broiler chicks. According to the study summary provided by Latest Results, intracerebroventricular injection of adropin reduced food intake, with evidence that neuropeptide Y1, melanocortin 3, and melanocortin 4 receptors are involved in mediating that response. The finding adds a new candidate peptide to the growing map of neuroendocrine signals that shape appetite in broilers. (journals.physiology.org)

The result fits into a broader body of work examining how central signaling pathways regulate intake in young poultry. In birds, appetite control has increasingly been framed through interactions among hypothalamic peptides, peripheral nutrient signals, and the gut-brain axis. A recent review in Poultry Science described avian appetite regulation as a key factor not only in feed efficiency, but also in metabolic disorders and welfare outcomes in high-yield broilers. Industry guidance likewise emphasizes the importance of early chick feeding behavior during the brooding period because it influences start quality and downstream performance. (sciencedirect.com)

What appears to distinguish this study is its receptor-level focus. Based on the source summary, the appetite-suppressing effect of central adropin was linked to NPY1, MC3, and MC4 receptor signaling. That matters because those pathways sit at the center of established feeding circuits. NPY signaling is typically associated with orexigenic drive, while melanocortin pathways are well known for satiety signaling across species. Inference: if adropin’s effect is being blocked or shaped through these receptors, the peptide may be interacting with one of the core central switches that determine whether neonatal chicks initiate or suppress feeding. That interpretation is consistent with broader adropin literature describing the peptide as a regulator of metabolic homeostasis, although mammalian reviews note that adropin’s direct feeding effects have not always been consistent across models. (journals.physiology.org)

Additional poultry research suggests this is not an isolated line of inquiry. A 2026 British Poultry Science paper examined central adropin in broiler chickens in relation to dopaminergic and serotonergic systems, indicating that researchers are actively probing how adropin interfaces with multiple neurotransmitter networks in avian feeding control. Separate work in neonatal broiler chicks has also linked other peptides, including spexin, to reduced intake through melanocortin-related mechanisms. Together, those studies point to a broader research trend: identifying overlapping central pathways that may explain satiety responses in rapidly growing birds. (tandfonline.com)

Direct outside commentary on this specific paper was limited in the available search results, and no clear institutional press release surfaced. Even so, the surrounding literature helps frame likely industry interest. Researchers and nutrition specialists are paying closer attention to neuroendocrine regulators because modern broiler production depends on balancing aggressive growth targets with metabolic resilience, welfare, and efficient feed conversion. Mechanistic studies like this one can help clarify which signals are biologically meaningful, even when the experimental approach itself is far removed from commercial practice. (sciencedirect.com)

Why it matters: For veterinary professionals, this is a useful signal-generation study rather than a practice-changing one. The work appears to strengthen the case that neonatal feed intake is shaped by a tightly integrated central network involving orexigenic and anorexigenic pathways, and that adropin may be one more lever within that system. In practical terms, it won’t change ration formulation or brooding protocols tomorrow, because intracerebroventricular injection is an experimental tool, not a scalable intervention. But the findings could inform future research on biomarkers of appetite, selection targets tied to feed efficiency, or nutritional programs designed to influence endogenous satiety signaling during the critical early-life window. (journals.physiology.org)

What to watch: The most important next questions are whether adropin has similar effects when manipulated indirectly or peripherally, whether the response persists beyond the neonatal period, and whether any measurable impact emerges on growth, feed conversion, metabolic health, or welfare under commercial conditions. If follow-up work continues to connect adropin with established appetite pathways, it could become a more relevant marker in poultry nutrition and physiology research over the next few years. (pmc.ncbi.nlm.nih.gov)